PEDIARIX is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated); Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated); Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated); Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated); Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen; Poliovirus Type 1 Antigen (formaldehyde Inactivated); Poliovirus Type 2 Antigen (formaldehyde Inactivated); Poliovirus Type 3 Antigen (formaldehyde Inactivated).
Product ID | 58160-811_11ed1826-1e2e-40b3-a2cc-c53bf2c4e177 |
NDC | 58160-811 |
Product Type | Vaccine |
Proprietary Name | PEDIARIX |
Generic Name | Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Hepatitis B (recombinant) And Inactivated Poliovirus Vaccine Combined |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2009-07-24 |
Marketing Category | BLA / BLA |
Application Number | BLA103907 |
Labeler Name | GlaxoSmithKline Biologicals SA |
Substance Name | BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
Active Ingredient Strength | 25 ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL |
Pharm Classes | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2009-07-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 2010-08-25 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Marketing Start Date | 2009-07-24 |
Marketing End Date | 2012-08-22 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 2010-08-25 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Marketing Start Date | 2010-04-06 |
Marketing End Date | 2013-10-30 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Marketing Start Date | 2009-07-24 |
Marketing End Date | 2012-04-13 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Marketing Start Date | 2009-07-24 |
Marketing End Date | 2012-04-13 |
Marketing Category | BLA |
Application Number | BLA103907 |
Product Type | VACCINE |
Marketing Start Date | 2009-07-24 |
Marketing End Date | 2013-10-30 |
Ingredient | Strength |
---|---|
CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 25 [iU]/.5mL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PEDIARIX 78125641 2978215 Live/Registered |
GLAXOSMITHKLINE BIOLOGICALS S.A. 2002-05-02 |
PEDIARIX 78125636 3090864 Live/Registered |
GLAXOSMITHKLINE LLC 2002-05-02 |
PEDIARIX 78125385 not registered Dead/Abandoned |
SmithKline Beecham Corporation 2002-05-01 |
PEDIARIX 78080467 2730703 Live/Registered |
Glaxosmithkline Biologicals S.A. 2001-08-22 |